glp 1 pill novo nordisk launches Wegovy weight-loss in US, triggering price war | Pharmaceuticals industry Novo and Lilly gain on

Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome

Demand has significantly outstripped supply, with Novo Nordisk even limiting new prescriptions in the US due to manufacturing constraints

The peptides unique ability to bind copper ions enhances its biological activity, as copper serves as a cofactor for numerous enzymes essential to skin health and wound healing

Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial

Lifestyle factors also play important roles: Regular physical activity : Exercise improves insulin sensitivity and may enhance incretin responses, though effects on fasting GLP-1 levels are variable